Dr. Charles S Hesdorffer MD
Hematologist-Oncologist | Hematology & Oncology
3001 S Hanover St Nia At Harbor Hospit Brooklyn MD, 21225About
Dr. Charles Hesdorffer is a hematologist oncologist practicing in Brooklyn, MD. Dr. Hesdorffer specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
University of The Witwatersrand, Faculty of Health Sciences,Parktown, South Africa 1978
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Wild-type p53 epitope naturally processed and presented by an HLA-B haplotype on human breast carcinoma cells.
- A phase I study of high-dose BCNU, etoposide and escalating-dose thiotepa (BTE) with hematopoietic progenitor cell support in adults with recurrent and high-risk brain tumors.
- CD34+ cell dose requirements for rapid engraftment in a sequential high-dose chemotherapy regimen of paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin (CTCb) with PBPC support in metastatic breast cancer.
- The pharmacokinetics and pharmacodynamics of high-dose paclitaxel monotherapy (825 mg/m2 continuous infusion over 24 h) with hematopoietic support in women with metastatic breast cancer.
- Reduction of paclitaxel-induced peripheral neuropathy with glutamine.
- Transcript profiling of human dendritic cells maturation-induced under defined culture conditions: comparison of the effects of tumour necrosis factor alpha, soluble CD40 ligand trimer and interferon gamma.
- Tandem transplantation in lymphoma.
- Phase II trial of sequential high-dose chemotherapy with paclitaxel, melphalan and cyclophosphamide, thiotepa and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer.
- Multiepitope CD8(+) T cell response to a NY-ESO-1 peptide vaccine results in imprecise tumor targeting.
- Decreased binding of peptides-MHC class I (pMHC) multimeric complexes to CD8 affects their binding avidity for the TCR but does not significantly impact on pMHC/TCR dissociation rate.
- A monoclonal melanoma-specific T-cell population phenotypically indistinguishable from CD3+ LGL-leukemia.
- Gene expression profiling and functional activity of human dendritic cells induced with IFN-alpha-2b: implications for cancer immunotherapy.
- SSX antigens as tumor vaccine targets in human sarcoma.
- Shifting gene expression profiles during ex vivo culture of renal tumor cells: implications for cancer immunotherapy.
- An immunodominant SSX-2-derived epitope recognized by CD4+ T cells in association with HLA-DR.
Dr. Charles S Hesdorffer MD's Practice location
Dr. Charles Hesdorffer, MD
3001 S Hanover St Nia At Harbor Hospit -Brooklyn, MD 21225Get Direction
Dr. Charles S Hesdorffer MD's reviews
Write ReviewRecommended Articles
![]()
Inspirational Blood Cancer SurvivorsDifferent forms of blood cancer are responsible for claiming the third most lives out of all the types of cancer. Additionally, there are currently no known preventative treatments for blood cancers, and the disease also impacts children and young people more than any other form of cancer.When it...
![]()
Stem Cell Therapy Puts 4-year-old's Ultra Rare Lymphoma in Remission4-year-old Jovon Moss was diagnosed with X-linked Lymphoproliferative Syndrome, a rare disorder of the immune system that led him to being taken back and forth to the hospital since his 3rd birthday.Jovon’s journey began in September of last year, when his mother, Brittany Fluellen, first began to...
![]()
Living as a Hodgkin Lymphoma Survivor: Creating a New NormalNo one can ever truly be prepared for what it is like to live with cancer. Even the strongest survivors face setbacks, and some of the fiercest warriors share their stories of how they find their "new normals."Kimberly's storyWhen she was only 25, just five days before her wedding, Kimberly felt a...
![]()
'Robocop' Stem Cells Developed to Fight CancerCancer is the second-leading cause of death in the United States, although due to several advancements in cancer screening and treatment, survival rates have begun to improve.A new cancer therapyResearchers at the University of Minnesota and Mayo Clinic have developed a new type of cancer therapy...
![]()
'Sophie the Brave' Fights Childhood T-Cell LymphomaThe story of 2-year-old Sophie Skiles and her arduous battle with T-cell lymphoma pulls at one’s heartstrings while also causing one to marvel at the faith of her Mom, Shelby.The public first learned of Sophie when a newscast about her was posted online October 20, 2017. (KLTB/abc) It soon made it...
![]()
Lymphoma, the Persistence of Inspirational Women, and the Power of LanguageEach year, Leukemia and Blood Cancer New Zealand (LBC) sponsors their Blood Cancer Patient Forum. They invite speakers to bring them news about such topics as treatment advances and management of cancer from a fully developed psycho-social perspective. Essentially, they dish up good old-fashioned...
Nearby Providers
![]()
Dr. Yin Wu MD2401 W BELVEDERE AVE BALTIMORE MD 21215![]()
Ugochukwu A. Odo5406 FAIRLAWN AVE BALTIMORE MD 21215![]()
Dr. Jean Yared M.D.22 S Greene St Baltimore MD 21201![]()
Dr. Ann Butler Zimrin M.D.22 S Greene St Baltimore MD 21201![]()
Dr. Young Joo Lee M.D.3001 S Hanover St Brooklyn MD 21225![]()
Miss Ani Balmanoukian M.D.1800 Orleans St Baltimore MD 21287
